Evidence map›Paper›PMID 28817097›Full record

ArticleBiosensors2017

Bloch Surface Waves Biosensors for High Sensitivity Detection of Soluble ERBB2 in a Complex Biological Environment.

Alberto Sinibaldi, Camilla Sampaoli, Norbert Danz, Peter Munzert, Frank Sonntag, Fabio Centola, Agostino Occhicone, Elisa Tremante, Patrizio Giacomini, Francesco Michelotti

Abstract read
In one paragraph

Article in Biosensors, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alberto SinibaldiDepartment of Basic and Applied Science for Engineering, Sapienza University of Rome, Via A. Scarpa 16, 00161 Rome, Italy. alberto.sinibaldi@uniroma1.it.
Camilla SampaoliRegina Elena National Cancer Institute, Via E. Chianesi 53, 00144 Rome, Italy. camilla.sampaoli@gmail.com.
Norbert DanzFraunhofer Institute for Applied Optics and Precision Engineering IOF, Albert-Einstein-Str. 7, 07745 Jena, Germany. norbert.danz@iof.fraunhofer.de.
Peter MunzertFraunhofer Institute for Applied Optics and Precision Engineering IOF, Albert-Einstein-Str. 7, 07745 Jena, Germany. peter.munzert@iof.fraunhofer.de.
Frank SonntagFraunhofer Institute for Material and Beam Technology IWS, Winterbergstr. 28, 01277 Dresden, Germany. frank.sonntag@iws.fraunhofer.de.
Fabio CentolaIBI-Istituto Biochimico Italiano Giovanni Lorenzini Spa, Via Fossignano 2, 04011 Aprilia, Italy. fcentola@ibi-lorenzini.com.
Agostino OcchiconeDepartment of Basic and Applied Science for Engineering, Sapienza University of Rome, Via A. Scarpa 16, 00161 Rome, Italy. agostino.occhicone@uniroma1.it.
Elisa TremanteRegina Elena National Cancer Institute, Via E. Chianesi 53, 00144 Rome, Italy. etremante@gmail.com.
Patrizio GiacominiRegina Elena National Cancer Institute, Via E. Chianesi 53, 00144 Rome, Italy. patrizio.giacomini@ifo.gov.it.
Francesco MichelottiDepartment of Basic and Applied Science for Engineering, Sapienza University of Rome, Via A. Scarpa 16, 00161 Rome, Italy. francesco.michelotti@uniroma1.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report on the use of one-dimensional photonic crystals to detect clinically relevant concentrations of the cancer biomarker ERBB2 in cell lysates. Overexpression of the ERBB2 protein is associated with aggressive breast cancer subtypes. To detect soluble ERBB2, we developed an optical set-up which operates in both label-free and fluorescence modes. The detection approach makes use of a sandwich assay, in which the one-dimensional photonic crystals sustaining Bloch surface waves are modified with monoclonal antibodies, in order to guarantee high specificity during the biological recognition. We present the results of exemplary protein G based label-free assays in complex biological matrices, reaching an estimated limit of detection of 0.5 ng/mL. On-chip and chip-to-chip variability of the results is addressed too, providing repeatability rates. Moreover, results on fluorescence operation demonstrate the capability to perform high sensitive cancer biomarker assays reaching a resolution of 0.6 ng/mL, without protein G assistance. The resolution obtained in both modes meets international guidelines and recommendations (15 ng/mL) for ERBB2 quantification assays, providing an alternative tool to phenotype and diagnose molecular cancer subtypes.

Indexed as

PhotonsBiomarkers, TumorBiosensing TechniquesCell Line, TumorErb-b2 Receptor Tyrosine KinasesHumansLimit of DetectionMolecular Diagnostic TechniquesOptical ImagingReproducibility of ResultsBiomarkers, TumorERBB2 protein, humanErb-b2 Receptor Tyrosine Kinases1D photonic crystalsBloch surface wavesBreast cancerERBB2Optical biosensorsSK-BR 3

Identifiers

PMID28817097
PMCPMC5618039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.